Predictive Factors of the Treatment Failure in HCV Mono-infected Patients Treated With Pegylated-interferon/Ribavirin/Telaprevir.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Peginterferon; Ribavirin; Telaprevir
- Indications Hepatitis C
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms GENUPI
- 22 Jun 2016 Biomarkers information updated
- 23 Apr 2012 New trial record